These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 8994482

  • 21. Brain blood flow in the dementias: SPECT with histopathologic correlation in 54 patients.
    Bonte FJ, Weiner MF, Bigio EH, White CL.
    Radiology; 1997 Mar; 202(3):793-7. PubMed ID: 9051035
    [Abstract] [Full Text] [Related]

  • 22. Concordance between (99m)Tc-ECD SPECT and 18F-FDG PET interpretations in patients with cognitive disorders diagnosed according to NIA-AA criteria.
    Ito K, Shimano Y, Imabayashi E, Nakata Y, Omachi Y, Sato N, Arima K, Matsuda H.
    Int J Geriatr Psychiatry; 2014 Oct; 29(10):1079-86. PubMed ID: 24687634
    [Abstract] [Full Text] [Related]

  • 23. Heterogeneity of neocortical cerebral blood flow deficits in dementia of the Alzheimer type: a [99mTc]-d,l-HMPAO SPECT study.
    Waldemar G, Bruhn P, Kristensen M, Johnsen A, Paulson OB, Lassen NA.
    J Neurol Neurosurg Psychiatry; 1994 Mar; 57(3):285-95. PubMed ID: 8158175
    [Abstract] [Full Text] [Related]

  • 24. Accuracy of single-photon emission computed tomography in differentiating frontotemporal dementia from Alzheimer's disease.
    McNeill R, Sare GM, Manoharan M, Testa HJ, Mann DM, Neary D, Snowden JS, Varma AR.
    J Neurol Neurosurg Psychiatry; 2007 Apr; 78(4):350-5. PubMed ID: 17158559
    [Abstract] [Full Text] [Related]

  • 25. The role of PET/CT amyloid Imaging compared with Tc99m-HMPAO SPECT imaging for diagnosing Alzheimer's disease.
    Suppiah S, Ching SM, Nordin AJ, Vinjamuri S.
    Med J Malaysia; 2018 Jun; 73(3):141-146. PubMed ID: 29962497
    [Abstract] [Full Text] [Related]

  • 26. Abnormalities in rCBF and computed tomography in patients with Alzheimer's disease and in controls.
    Wyper D, Teasdale E, Patterson J, Montaldi D, Brown D, Hunter R, Graham D, McCulloch J.
    Br J Radiol; 1993 Jan; 66(781):23-7. PubMed ID: 8428246
    [Abstract] [Full Text] [Related]

  • 27. Brain perfusion SPECT with an automated quantitative tool can identify prodromal Alzheimer's disease among patients with mild cognitive impairment.
    Habert MO, Horn JF, Sarazin M, Lotterie JA, Puel M, Onen F, Zanca M, Portet F, Touchon J, Verny M, Mahieux F, Giron A, Fertil B, Dubois B.
    Neurobiol Aging; 2011 Jan; 32(1):15-23. PubMed ID: 19250707
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. High-resolution technetium-99m-HMPAO SPECT in patients with probable Alzheimer's disease: comparison with fluorine-18-FDG PET.
    Messa C, Perani D, Lucignani G, Zenorini A, Zito F, Rizzo G, Grassi F, Del Sole A, Franceschi M, Gilardi MC.
    J Nucl Med; 1994 Feb; 35(2):210-6. PubMed ID: 8294987
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Association between medial temporal lobe atrophy on CT and parietotemporal uptake decrease on SPECT in Alzheimer's disease.
    Lavenu I, Pasquier F, Lebert F, Jacob B, Petit H.
    J Neurol Neurosurg Psychiatry; 1997 Oct; 63(4):441-5. PubMed ID: 9343120
    [Abstract] [Full Text] [Related]

  • 32. The clinical utility of visual evaluation of scintigraphic perfusion patterns for Alzheimer's disease using I-123 IMP SPECT.
    Ishii K, Mori E, Kitagaki H, Sakamoto S, Yamaji S, Imamura T, Ikejiri Y, Kono M.
    Clin Nucl Med; 1996 Feb; 21(2):106-10. PubMed ID: 8697677
    [Abstract] [Full Text] [Related]

  • 33. SPECT in Alzheimer's disease: features associated with bilateral parietotemporal hypoperfusion.
    Nitrini R, Buchpiguel CA, Caramelli P, Bahia VS, Mathias SC, Nascimento CM, Degenszajn J, Caixeta L.
    Acta Neurol Scand; 2000 Mar; 101(3):172-6. PubMed ID: 10705939
    [Abstract] [Full Text] [Related]

  • 34. Evaluation of diagnostic strategies for bladder cancer using computed tomography (CT) urography, flexible cystoscopy and voided urine cytology: results for 778 patients from a hospital haematuria clinic.
    Blick CG, Nazir SA, Mallett S, Turney BW, Onwu NN, Roberts IS, Crew JP, Cowan NC.
    BJU Int; 2012 Jul; 110(1):84-94. PubMed ID: 22122739
    [Abstract] [Full Text] [Related]

  • 35. Technetium-99m HM-PAO-SPECT study of regional cerebral perfusion in early Alzheimer's disease.
    Perani D, Di Piero V, Vallar G, Cappa S, Messa C, Bottini G, Berti A, Passafiume D, Scarlato G, Gerundini P.
    J Nucl Med; 1988 Sep; 29(9):1507-14. PubMed ID: 3261784
    [Abstract] [Full Text] [Related]

  • 36. Utility of (99m)Tc-HM-PAO SPECT hippocampal image to diagnose early stages of Alzheimer's disease using semiquantitative analysis.
    Nebu A, Ikeda M, Fukuhara R, Komori K, Maki N, Hokoishi K, Shigenobu K, Kikuchi T, Tanabe H.
    Dement Geriatr Cogn Disord; 2001 Sep; 12(2):153-7. PubMed ID: 11173889
    [Abstract] [Full Text] [Related]

  • 37. CBF tomograms with [99mTc-HM-PAO in patients with dementia (Alzheimer type and HIV) and Parkinson's disease--initial results.
    Costa DC, Ell PJ, Burns A, Philpot M, Levy R.
    J Cereb Blood Flow Metab; 1988 Dec; 8(6):S109-15. PubMed ID: 3263977
    [Abstract] [Full Text] [Related]

  • 38. MRI-guided SPECT measurements of medial temporal lobe blood flow in Alzheimer's disease.
    Julin P, Lindqvist J, Svensson L, Slomka P, Wahlund LO.
    J Nucl Med; 1997 Jun; 38(6):914-9. PubMed ID: 9189141
    [Abstract] [Full Text] [Related]

  • 39. The use of technetium-99m-HM-PAO in the assessment of patients with dementia and other neuropsychiatric conditions.
    Smith FW, Besson JA, Gemmell HG, Sharp PF.
    J Cereb Blood Flow Metab; 1988 Dec; 8(6):S116-22. PubMed ID: 2973469
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.